Global Custom Market Research Reports Provider Company

phone

Advanced Accelerator Applications SA (AAAP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 43
  • Category: Pharmaceuticals
  • Country: France
Summary

Advanced Accelerator Applications SA (AAA) is a healthcare products provider that offers molecular nuclear medicine and diagnostic and therapeutic products. The companys lead product candidate comprises Lutathera, a lutetium-177 somatostatin analogue peptide that is used for the treatment of midgut neuroendocrine tumors. It provides positron emission tomography and single photon emission computed tomography products. AAA caters to diagnosis in clinical cardiology, oncology, neurology, and infectious and inflammatory diseases. It operates in France, Italy, the UK, Germany, Switzerland, Spain, Poland, Portugal, Israel, the US, and Canada, among others. AAA is headquartered in Saint-Genis-Pouilly, France.

Advanced Accelerator Applications SA (AAAP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Advanced Accelerator Applications SA, Medical Devices Deals, 2012 to YTD 2018 9
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Advanced Accelerator Applications Raises USD26 Million in Venture Financing 12
Advanced Accelerator Applications Raises US$56 Million In Venture Financing 13
Advanced Accelerator Raises US$6 Million In First Tranche Of Venture Financing 14
Partnerships 15
Advanced Accelerator Applications Enters into Agreement with National Cancer Institute 15
Vect-Horus Enters into Collaboration Agreement with Advanced Accelerator Applications for Radio-Imaging Agents 16
Licensing Agreements 17
Advanced Accelerator Enters into Licensing Agreement with Cancer Targeted Technology 17
Advanced Accelerator Applications Enters into Licensing Agreement with Erasmus University Medical Center and Demokritos National Center 18
Advanced Accelerator Applications Enters into Licensing Agreement with Johns Hopkins University 19
Fujifilm RI Pharma Enters into Licensing Agreement with Advanced Accelerator Applications 20
Equity Offering 21
Advanced Accelerator Applications Prices Public Offering of American Depositary Shares for USD172.5 Million 21
Advanced Accelerator Applications to Raise up to USD80 Million in IPO 23
Acquisition 25
Novartis Acquires Advanced Accelerator Applications for USD3.9 Billion 25
Advanced Accelerator Applications Acquires IDB Group 27
Advanced Accelerator Applications Acquires Remaining 49.9% Stake in Atreus Pharma 28
Advanced Accelerator Applications SA - Key Competitors 29
Advanced Accelerator Applications SA - Key Employees 30
Advanced Accelerator Applications SA - Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 33
Financial Announcements 33
Nov 17, 2017: Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017 33
Aug 31, 2017: Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017 34
May 31, 2017: Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017 36
Mar 23, 2017: Advanced Accelerator Applications Reports 23% Sales Growth for Fiscal 2016; Continued NETSPOT Launch Success 38
Corporate Communications 40
May 25, 2017: Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors 40
Other Significant Developments 41
Jan 09, 2017: Advanced Accelerator Applications CEO Provides Progress Report on Corporate Developments of 2016; Asserts Confidence in Ability to Address FDA Comments on Lutathera NDA 41
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List Of Tables

List of Tables
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced Accelerator Applications SA, Deals By Therapy Area, 2012 to YTD 2018 8
Advanced Accelerator Applications SA, Medical Devices Deals, 2012 to YTD 2018 9
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Advanced Accelerator Applications Raises USD26 Million in Venture Financing 12
Advanced Accelerator Applications Raises US$56 Million In Venture Financing 13
Advanced Accelerator Raises US$6 Million In First Tranche Of Venture Financing 14
Advanced Accelerator Applications Enters into Agreement with National Cancer Institute 15
Vect-Horus Enters into Collaboration Agreement with Advanced Accelerator Applications for Radio-Imaging Agents 16
Advanced Accelerator Enters into Licensing Agreement with Cancer Targeted Technology 17
Advanced Accelerator Applications Enters into Licensing Agreement with Erasmus University Medical Center and Demokritos National Center 18
Advanced Accelerator Applications Enters into Licensing Agreement with Johns Hopkins University 19
Fujifilm RI Pharma Enters into Licensing Agreement with Advanced Accelerator Applications 20
Advanced Accelerator Applications Prices Public Offering of American Depositary Shares for USD172.5 Million 21
Advanced Accelerator Applications to Raise up to USD80 Million in IPO 23
Novartis Acquires Advanced Accelerator Applications for USD3.9 Billion 25
Advanced Accelerator Applications Acquires IDB Group 27
Advanced Accelerator Applications Acquires Remaining 49.9% Stake in Atreus Pharma 28
Advanced Accelerator Applications SA, Key Competitors 29
Advanced Accelerator Applications SA, Key Employees 30
Advanced Accelerator Applications SA, Subsidiaries 31

List Of Figures

List of Figures
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced Accelerator Applications SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Advanced Accelerator Applications SA, Medical Devices Deals, 2012 to YTD 2018 9

REASONS FOR DOING THE STUDY Advances in medical science, research and development (R&D), and innovation are changing the dynamics of the life sciences industry, including biotechnology, pharmaceuticals and healthcare. The development

View Report

The global market size of Advanced Wound Management is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the

View Report

The global market size of Advanced Wound Care systems is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports